Epstein-Barr virus infection induces lupus autoimmunity

Area of Science:

• Immunology
• Rheumatology
• Virology

Background:

• Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical features, unified by autoantibodies.
• Genetic and environmental factors contribute to SLE development.
• Abnormal autoantibody responses precede SLE diagnosis by years.

Purpose of the Study:

• To investigate the role of Epstein-Barr virus (EBV) infection in the initiation of SLE autoimmunity.
• To identify early autoantibody targets in SLE development.

Main Methods:

• Analysis of autoantibody responses in individuals who later develop SLE.
• Identification of autoantibody targets, including anti-Sm B' and anti-60 kD Ro.
• Investigation of immune responses to EBV, specifically against EBV Nuclear Antigen-1 (EBNA-1).

Main Results:

• The first lupus-specific autoantibodies may arise from antibodies targeting EBNA-1.
• Antibodies against EBNA-1 can cross-react with lupus-specific autoantigens (Sm or Ro).
• Individuals developing SLE exhibit unusual immune responses to EBV.

Conclusions:

• Epstein-Barr virus infection is a potential environmental risk factor for SLE.
• Immune responses to EBV may be crucial in initiating lupus autoimmunity in some patients.
• A proposed sequence involves EBV infection, anti-EBNA-1 antibodies, cross-reactivity with autoantigens, and subsequent autoimmune progression.